Novartis AG (Switzerland)
F. Hoffman-La Roche AG (Switzerland)
AbbVie Inc. (U.S.)
Pfizer Inc. (U.S.)
AstraZeneca (U.K.)
Bayer AG (Germany)
Amgen (U.S.)
GlaxoSmithKline Plc (U.K.)
Sanofi (France)
Eli Lilly and Company (U.S.)
Published | Pages | Publisher | Report code |
---|---|---|---|
Feb 2019 | 138 | Market Research Future | ASDR-482905 |
Novartis AG (Switzerland)
F. Hoffman-La Roche AG (Switzerland)
AbbVie Inc. (U.S.)
Pfizer Inc. (U.S.)
AstraZeneca (U.K.)
Bayer AG (Germany)
Amgen (U.S.)
GlaxoSmithKline Plc (U.K.)
Sanofi (France)
Eli Lilly and Company (U.S.)